According to filings with the U.S. Securities and Exchange Commission, Eyecheq is raising up to $11,452,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Eyecheq
EyeCheq’s mission is to prevent blindness and enable earlier intervention by local eye doctors as we detect conditions indicating diabetic retinopathy, macular degeneration, and others. Our autonomous kiosk-based experience includes a retinal image and visual acuity test along with remote doctor and AI interpretation, enabling us to improve HEDIS scores related to Quality and Diabetic Eye Exams for our partner Health Plans and Providers. Our Tele-Ophthalmology Platform including kiosks are coming in 2023 to retail, pharmacy and provider locations.

To learn more, visit https://www.eyecheq.com/
LinkedIn: https://www.linkedin.com/company/eyecheq/

Contact:
Rashid Taher, Chief Executive Officer
https://www.linkedin.com/in/rashid-taher-9a6798/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.